http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101647569-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
filingDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101647569-B1
titleOfInvention Combination therapy for ovarian cancer
abstract The present invention relates to a pharmaceutical composition comprising gemcitabine, cisplatin or carboplatin and 5- [2-tert-butyl-5- (4-fluoro-phenyl) Dimethyl-propyl) -3H-imidazo [4,5-b] pyridin-2-ylamine in a mammal in need of such treatment. .
priorityDate 2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005075478-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89560724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431136986

Total number of triples: 24.